Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07217743 · ClinicalTrials.gov registry record · Phase 2
Assess Impact of Poly-L-lactic Acid on GLP1 Subjects
A Phase 2 study, sponsored by Goldman, Butterwick, Fitzpatrick and Groff.
- Not yet
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
NCT07217743 is a Phase 2 study that has not yet begun recruiting, run by Goldman, Butterwick, Fitzpatrick and Groff. The registered enrollment target is 20 participants.
The verdict
NCT07217743, a Phase 2 study, has not yet begun recruiting, sponsored by Goldman, Butterwick, Fitzpatrick and Groff.
- NOT YET RECRUITING
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
Study Summary
Clinical trial to evaluate treatments of double-dilute poly-L-lactic acid on abdominal skin laxity in GLP1 patients versus non GLP1 patients.
Interventions
- DEVICE Sculptra Aesthetic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-10-27 |
| Est. Completion | 2026-10-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07217743
The ClinicalTrials.gov registry entry for NCT07217743 describes a study currently listed as not yet recruiting, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Goldman, Butterwick, Fitzpatrick and Groff, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sculptra Aesthetic is the first listed.
NCT07217743 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07217743 about?
NCT07217743 is a clinical study titled "Assess Impact of Poly-L-lactic Acid on GLP1 Subjects". Clinical trial to evaluate treatments of double-dilute poly-L-lactic acid on abdominal skin laxity in GLP1 patients versus non GLP1 patients.
What is the current status of trial NCT07217743?
This trial is currently not yet recruiting. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2025-10-27. Estimated completion is 2026-10-31.
What interventions are being tested in trial NCT07217743?
The interventions under investigation include: Sculptra Aesthetic (DEVICE).
Who is sponsoring clinical trial NCT07217743?
This trial is sponsored by Goldman, Butterwick, Fitzpatrick and Groff, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.